MedX Health Corp. (MedX) announced that it has signed a Memorandum of Understanding with CBD Vida LTDA, who plans to launch an ease-of-access skin scanning/assessment program throughout Brazil, using MedX’s DermSecureTM. Telemedicine platform. There is a significant opportunity for MedX’s skin imaging technology in Brazil, as skin cancer is the most common type of cancer in Brazil. More than one hundred thousand new cases of skin cancer were recorded in Brazil between 2016 and 2017, according to the Brazilian Cancer Institute, and almost 6,000 were classified as melanoma, an aggressive form of the disease that can spread to other parts of the body. A recent study shows that Brazilian melanoma patients experienced a lower survival rate than the current worldwide average. The high prevalence of advanced cases reinforces the importance of local strategies to diagnose melanomas in the early stages, and to treat it definitively. “MedX’s DermSecureTM telemedicine platform and advanced SIAscopy imaging technology is a perfect solution for early detection.